Medical devices solicitors welcome Breast Implant Illness acknowledgment by MHRA
Product liability solicitor, Zahra Nanji, who represents a group of women who are taking legal action in relation to textured breast implants, have welcomed the acknowledgment of Breast Implant Illness by the MHRA.
Posted on 20 January 2020
BII is a term often used by women who have received breast implants and who have suffered a spectrum of health problems, which the MHRA statement refers to as ‘brain fog’, fatigue, anxiety and joint pain. The MHRA statement also acknowledges that it has received reports of breast implants in association with autoimmune disorders.
Leigh Day is currently pursing claims on behalf of women who have had a diagnosis of BIA-ALCL or are being investigated for BIA-ALCL, a rare form of cancer linked to textured breast implants. While BIA-ALCL and BII are not linked, in the course of pursuing the claims for BIA-ALCL the legal team at Leigh Day have spoken to many women who have also reported suffering from symptoms of BII.
“The MHRA’s latest statement on BII, the increasing number of women diagnosed with BIA-ALCL, means that real questions need to be asked about whether any breast implant is ever safe.
“The MHRA statement is in part a response to campaigning of women affected by BII, including campaigning journalist Abbie Eastwood, and who has been critical in securing this formal acknowledgment that symptoms known of BII are experienced by women who undergo breast augmentation irrespective of brand.”